Zumwalt Debra sold $14K of HURN

Huron (HURN) reported fastest revenue growth and highest guidance raise, with stock up 28.9%. Concentrix (CNXC) had weakest Q2, missing EPS and revenue guidance, but stock up 9.7%. Genpact (G) reported mixed results, with stock up 2.2%. TaskUs (TASK) beat revenue expectations, stock up 22.9%.

Huron reported Q2 CY2026 revenue of $475M vs $460.4M estimates, and adjusted EPS of $2.46 vs $2.17, with adjusted EBITDA of $72.64M. The company raised full-year guidance to $1.87B revenue and $9.20 adjusted EPS midpoint. Management attributed growth to AI-enabled solutions and managed services expansion, including outcome-based contracts.

Strategic Performance Drivers Achieved record RBR growth of 16% driven by strong organic performance across all three segments and a meaningful step-up in digital capabilities. Healthcare segment growth of 17% was fueled by persistent financial challenges for providers, including rising labor and supply costs that outpace reimbursements.

Huron Consulting Group (HURN) shares rose 35.8% after the company reported Q2 results that beat analyst expectations and lifted its full-year outlook. Revenue was $475M, up 15.4% YoY versus $449M consensus. Adjusted EPS was $2.46 versus $2.17 forecast. Huron raised full-year revenue guidance to $1.87B midpoint and adjusted EPS to $9.20.

Huron Consulting Group (Huron) shares rose 32.11% to $160.34 after the firm reported Q2 adjusted EPS of $2.46 vs $2.17 expected and revenue of $475.0 million vs about $449 million expected. Huron raised 2026 guidance to revenue before reimbursable expenses of $1.85B-$1.89B and adjusted EPS of $9.00-$9.40, citing AI work and acquisitions including RelateCare.

Huron Consulting Group (HURN) reported Q2 CY2026 results. Revenue rose 15.4% year over year to $475 million, exceeding market estimates. Full-year revenue guidance midpoint was $1.87 billion, 2.4% above analysts’ expectations. Non-GAAP EPS was $2.46, 13.2% above consensus. Adjusted operating margin rose to 13.3% in Q2.